Prospective Study for the Treatment of Atherosclerotic Lesions in the Superficial Femoral And/or … (NCT03676842) | Clinical Trial Compass
TerminatedNot Applicable
Prospective Study for the Treatment of Atherosclerotic Lesions in the Superficial Femoral And/or Popliteal Arteries Using the FLEX Scoring Catheter Plus DCB
Stopped: Low enrollment- Hospital during COVID
United States9 participantsStarted 2018-10-11
Plain-language summary
Prospective, single-center, single-arm, non-randomized study to assess the safety and efficacy of the FLEX Scoring Catheter in patients with atherosclerotic peripheral artery disease in the superficial femoral and popliteal arteries.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Women of child-bearing potential must have a negative test within 7 days of the initial procedure
* Patient or patient's legal representative has been informed of the nature of the study, agrees to participate and comply with all follow-up visits, and has signed the informed consent.
* Patient is eligible for standard surgical repair in the target limb if necessary.
* Patient has Rutherford Clinical Category estimated as 2-6.
* A life expectancy \>1 year.
Angiographic Inclusion Criteria:
* Target lesion(s) is located within the SFA and/or the popliteal arteries.
* Target lesion has \>70% stenosis by visual assessment.
* The reference vessel diameter is between 4-6 mm.
* One long or multiple serial lesions.
* de novo or non-stented re-stenotic lesions.
* At least one BTK artery patent to the ankle.
* Successful treatment of iliac inflow stenosis to the target limb. Stenosis can be treated during the same procedure using standard angioplasty and/or stenting but atherectomy is excluded. The inflow lesion(s) must be treated first, before consideration of treatment of the target lesion. Subject can be enrolled if the treated inflow lesion(s) results in \<30% residual stenosis and no evidence of embolization or significant complications.
Exclusion Criteria:
* Rutherford Clinical Category 1.
* Previously implanted ipsilateral femoral or popliteal stent.
* Evidence of aneurysm or acute thrombus in the target vessel.
* Patients with previous bypass surgery i…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Technical feasibility of the FLEX Scoring Catheter
Timeframe: Through study completion: Approximately 12 months